TETERBORO, N.J., Sep 27, 2004 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it has been added to the Dow Jones
Sustainability World Index (DJSI World), effective September 20.
The Index contains more than 300 companies identified as "sustainability
leaders," ranked according to objective benchmarks linked to financial,
environmental and social criteria. The DJSI defines corporate sustainability
as "a business approach that creates long-term shareholder value by embracing
opportunities and managing risks deriving from economic, environmental and
social developments. Corporate sustainability leaders achieve long-term
shareholder value by gearing their strategies and management to harness the
market's potential for sustainability products and services while at the same
time successfully reducing and avoiding sustainability costs and risks."
"We are honored to be included in the Dow Jones Sustainability World
Index," said Surya N. Mohapatra, Ph.D., President and Chief Executive Officer
of Quest Diagnostics.
The DJSI World index was launched in 1999 as a way to help a growing
number of fund managers who base investment decisions on environmental and
social factors as well as financial performance. The index is produced by
Sustainable Asset Management Group, based in Zurich, Switzerland, together
with Dow Jones Indexes and STOXX Limited. Additional information about the
DJSI, including a list of all component companies, is available at:
http://www.sustainability-indexes.com.
About Quest Diagnostics
Quest Diagnostics Incorporated is the nation's leading provider of
diagnostic testing, information and services, providing insights that enable
healthcare professionals to make decisions that improve health. The company
offers the broadest access to diagnostic testing services through its national
network of laboratories and patient service centers, and provides interpretive
consultation through its extensive medical and scientific staff. Quest
Diagnostics is the leading provider of esoteric testing, including gene-based
medical testing, and provides advanced information technology solutions to
improve patient care. Additional company information is available at:
http://www.questdiagnostics.com
Statements in this press release which are not historical facts or
information may be forward-looking statements. These forward-looking
statements involve risks and uncertainties that could cause actual results and
outcomes to be materially different. Certain of these risks and uncertainties
may include, but are not limited to, competitive environment, changes in
government regulations, changing relationships with customers, payers,
suppliers and strategic partners and other factors described in the Quest
Diagnostics Incorporated 2003 Form 10-K and subsequent filings.
SOURCE Quest Diagnostics Incorporated
Laure Park, Investors, +1-201-393-5030, or Gary Samuels, Media,
+1-201-393-5700
(DGX)